Human-derived cathelicidin LL-37 directly activates mast cells to proinflammatory mediator synthesis and migratory

Edyta Bąbolewska1, Ewa Brzezińska-Błaszczyk1

  • 1Department of Experimental Immunology, Medical University of Łódź, Pomorska 251, 92-213 Łódź, Poland.

Cellular Immunology
|January 12, 2015
PubMed

Insights

Human cathelicidins like LL-37 activate mast cells, promoting inflammation. This antimicrobial peptide attracts mast cells to infection sites and triggers mediator release, enhancing the immune response against bacteria.

Area of Science:

  • Immunology
  • Microbiology
  • Biochemistry

Background:

  • Cathelicidins are antimicrobial peptides crucial for host defense against bacteria.
  • Beyond direct antimicrobial action, cathelicidins modulate inflammatory responses.
  • Mast cells play a significant role in inflammatory processes.

Purpose of the Study:

  • To investigate the effect of human cathelicidin LL-37 on mast cell activation.
  • To determine if LL-37 induces mast cell degranulation, cytokine production, and chemoattraction.

Main Methods:

  • Mast cell activation assays were performed.
  • Cytokine production and leukotriene generation were measured.
  • Intracellular signaling pathways (PLC/A2, MAPKs, PI3K) were analyzed.

Main Results:

  • LL-37 directly stimulated mast cell degranulation and proinflammatory cytokine release.
  • LL-37 did not induce cysteinyl leukotriene generation.
  • LL-37 demonstrated strong chemoattractant properties for mast cells.
  • Intracellular signaling involved PLC/A2, MAPKs, and PI3K.

Conclusions:

  • LL-37 activates mast cells, contributing to inflammatory responses.
  • Cathelicidins enhance antibacterial immunity by recruiting mast cells and inducing mediator release.
  • LL-37's role in mast cell activation has implications for host defense mechanisms.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
65.9K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K